Biogen Newsroom

RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksNov 28 09:47 · Ratings

Why Is Biogen Inc. (BIIB) Among the Worst Performing Healthcare Stocks in 2024?

Yahoo FinanceNov 27 22:15

Trump Taps Jay Bhattacharya to Lead National Institutes of Health

Seeking AlphaNov 27 19:23

"LEQEMBI" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea

BiogenNov 27 13:00

Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials Driving The Negative Sentiment?

Simply Wall StNov 26 22:53

Anavex Gains After Seeking EU Marketing Nod for Alzheimer's Drug

Seeking AlphaNov 26 21:55

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250

Futu NewsNov 25 23:30 · Ratings

Jefferies Remains a Buy on Biogen (BIIB)

TipRanksNov 25 23:26 · Ratings

Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?

BarchartNov 25 18:09

Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC

Seeking AlphaNov 23 10:25

Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock

Yahoo FinanceNov 22 20:45

Biogen Price Target Lowered to $207 From $251 at Mizuho

Yahoo FinanceNov 22 19:45

Optimism Over Global Healthcare Sector Rises: Jefferies

Seeking AlphaNov 22 02:45

Biogen Is Maintained at Outperform by Mizuho

Dow JonesNov 21 21:18 · Ratings

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $207

Futu NewsNov 21 20:31 · Ratings

European Commission Approves Samsung Bioepis, Biogen's Biosimilar Opuviz

MT NewswiresNov 21 12:07

Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside

BenzingaNov 21 02:32

Mizuho Securities Adjusts Price Target on Biogen to $207 From $251

MT NewswiresNov 20 23:13 · Ratings

Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now

Yahoo FinanceNov 20 08:06

Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data in Moderate-To-Severe Systemic Lupus

PR NewswireNov 20 00:01